These include a high positive selection on KAI14, KIF6 (both indicated in cardiomyopathy), and PDE11A (vasoregulation), as well as pathway enrichments for the renin-angiotensin system and the endothelin-1 pathway, identified in both WedAR and dN/dS analyses. This evidence concerns the gene PDE11A and cardiomyopathy.